You just read:

Janssen-Cilag International NV (Janssen) Submits European Marketing Authorisation Application for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline

News provided by

Janssen-Cilag International NV (Janssen)

Aug 31, 2012, 04:42 ET